BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 36087748)

  • 21. Hydroxyurea-loaded Fe
    Chaghervand MM; Torbati MB; Shaabanzadeh M; Ahmadi A; Tafvizi F
    Naunyn Schmiedebergs Arch Pharmacol; 2022 Jan; 395(1):51-63. PubMed ID: 34661718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preparation of pH-sensitive chitosan/polyvinylpyrrolidone/α-Fe
    Gerami SE; Pourmadadi M; Fatoorehchi H; Yazdian F; Rashedi H; Nigjeh MN
    Int J Biol Macromol; 2021 Mar; 173():409-420. PubMed ID: 33454326
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Supercritically dried superparamagnetic mesoporous silica nanoparticles for cancer theranostics.
    Vaz-Ramos J; Cordeiro R; Castro MMCA; Geraldes CFGC; Costa BFO; Faneca H; Durães L
    Mater Sci Eng C Mater Biol Appl; 2020 Oct; 115():111124. PubMed ID: 32600723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mesoporous silica coated SPIONs containing curcumin and silymarin intended for breast cancer therapy.
    Sadegha S; Varshochian R; Dadras P; Hosseinzadeh H; Sakhtianchi R; Mirzaie ZH; Shafiee A; Atyabi F; Dinarvand R
    Daru; 2022 Dec; 30(2):331-341. PubMed ID: 36197594
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polyetherimide-grafted Fe₃O₄@SiO2₂ nanoparticles as theranostic agents for simultaneous VEGF siRNA delivery and magnetic resonance cell imaging.
    Li T; Shen X; Chen Y; Zhang C; Yan J; Yang H; Wu C; Zeng H; Liu Y
    Int J Nanomedicine; 2015; 10():4279-91. PubMed ID: 26170664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PVP Surface-protected silica coated iron oxide nanoparticles for MR imaging application.
    Kermanian M; Sadighian S; Naghibi M; Khoshkam M
    J Biomater Sci Polym Ed; 2021 Jul; 32(10):1356-1369. PubMed ID: 33882784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Delivery of curcumin by a pH-responsive chitosan mesoporous silica nanoparticles for cancer treatment.
    Ahmadi Nasab N; Hassani Kumleh H; Beygzadeh M; Teimourian S; Kazemzad M
    Artif Cells Nanomed Biotechnol; 2018 Feb; 46(1):75-81. PubMed ID: 28278578
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Theranostic nanoparticles based on magnetic nanoparticles: design, preparation, characterization, and evaluation as novel anticancer drug carrier and MRI contrast agent.
    Nosrati H; Salehiabar M; Kheiri Manjili H; Davaran S; Danafar H
    Drug Dev Ind Pharm; 2018 Oct; 44(10):1668-1678. PubMed ID: 29848101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In situ decorated Au NPs on chitosan-encapsulated Fe
    Wang X; Almoallim HS; Cui Q; Alharbi SA; Yang H
    Int J Biol Macromol; 2021 Feb; 171():198-207. PubMed ID: 33310102
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preparation of wormlike polymeric nanoparticles coated with silica for delivery of methotrexate and evaluation of anticancer activity against MCF7 cells.
    Gharebaghi F; Dalali N; Ahmadi E; Danafar H
    J Biomater Appl; 2017 Apr; 31(9):1305-1316. PubMed ID: 28447548
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Uniform mesoporous dye-doped silica nanoparticles decorated with multiple magnetite nanocrystals for simultaneous enhanced magnetic resonance imaging, fluorescence imaging, and drug delivery.
    Lee JE; Lee N; Kim H; Kim J; Choi SH; Kim JH; Kim T; Song IC; Park SP; Moon WK; Hyeon T
    J Am Chem Soc; 2010 Jan; 132(2):552-7. PubMed ID: 20017538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thermal and pH responsive polymer-tethered multifunctional magnetic nanoparticles for targeted delivery of anticancer drug.
    Sahoo B; Devi KS; Banerjee R; Maiti TK; Pramanik P; Dhara D
    ACS Appl Mater Interfaces; 2013 May; 5(9):3884-93. PubMed ID: 23551195
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Magnetic bio-metal-organic framework nanocomposites decorated with folic acid conjugated chitosan as a promising biocompatible targeted theranostic system for cancer treatment.
    Nejadshafiee V; Naeimi H; Goliaei B; Bigdeli B; Sadighi A; Dehghani S; Lotfabadi A; Hosseini M; Nezamtaheri MS; Amanlou M; Sharifzadeh M; Khoobi M
    Mater Sci Eng C Mater Biol Appl; 2019 Jun; 99():805-815. PubMed ID: 30889755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced Intracellular Delivery of Curcumin by Chitosan-Lipoic Acid as Reduction-Responsive Nanoparticles.
    Rezaei S; Kashanian S; Bahrami Y; Zhaleh H; Cruz LJ
    Curr Pharm Biotechnol; 2021; 22(5):622-635. PubMed ID: 32720599
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Facile synthesis by a covalent binding reaction for pH-responsive drug release of carboxylated chitosan coated hollow mesoporous silica nanoparticles.
    Liu Q; Wang J; Yang L; Xia X; Wang M; Chen S; Zhu R; Wang Q; Wu X; Wang S
    IET Nanobiotechnol; 2018 Jun; 12(4):446-452. PubMed ID: 29768228
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel antibacterial polymeric nanocomposite for smart co-delivery of anticancer drugs.
    Zakerzadeh E; Alizadeh E; Samadi Kafil H; Mohammad Hassanzadeh A; Salehi R; Mahkam M
    Artif Cells Nanomed Biotechnol; 2017 Dec; 45(8):1509-1520. PubMed ID: 27899033
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sugar and pH dual-responsive snap-top nanocarriers based on mesoporous silica-coated Fe3O4 magnetic nanoparticles for cargo delivery.
    Qiu XL; Li QL; Zhou Y; Jin XY; Qi AD; Yang YW
    Chem Commun (Camb); 2015 Mar; 51(20):4237-40. PubMed ID: 25670321
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preparation and Evaluation of pH Sensitive Novel Anticancer Drug Carrier Based on Magnetic Chitosan Quartets.
    Danafar H; Asadi F; Sharafi A; Manjili HK
    Drug Res (Stuttg); 2019 Sep; 69(9):496-504. PubMed ID: 30912092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optical imaging and anticancer chemotherapy through carbon dot created hollow mesoporous silica nanoparticles.
    Kang MS; Singh RK; Kim TH; Kim JH; Patel KD; Kim HW
    Acta Biomater; 2017 Jun; 55():466-480. PubMed ID: 28373086
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thrombus-specific theranostic nanocomposite for codelivery of thrombolytic drug, algae-derived anticoagulant and NIR fluorescent contrast agent.
    Chang LH; Chuang EY; Cheng TM; Lin C; Shih CM; Wu AT; Jheng PR; Lu HY; Shih CC; Mi FL
    Acta Biomater; 2021 Oct; 134():686-701. PubMed ID: 34358695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.